vimarsana.com
Home
Live Updates
New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs : comparemela.com
New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs
Healthcare AI can guide drug selection to improve effectiveness, avoid waste and drive value for payers and patients.
Related Keywords
United States ,
Richardl Nicholas ,
Richard Nicholas ,
Duke University Graduate School Of Business ,
International Committee ,
Research Consortium ,
Network Research Consortium ,
Us Congress ,
Boston College ,
Combination Cancer Treatment Risk ,
Incorporating Cost ,
Value Data ,
Drug Selection Process ,
Barrier Face Covering ,
Duke University Graduate School ,
Medrxiv ,
Tpa Network Research Consortium ,
comparemela.com © 2020. All Rights Reserved.